MYC protein expression and copy number anomalies in early-stage HER2+ breast cancer in context of the NCCTG adjuvant trial, N9831.
- Citation:
- Molecular Markers in Cancer abstr 66
- Meeting Instance:
- ASCO MM 2010
- Year:
- 2010
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- M. M. Reinholz X. Geiger A. C. Dueck A. E. Wiktor W. L. Lingle C. Andorfer W. R. Sukov R. P. Ketterling R. B. Jenkins E. A. Perez N. E. Davidson S. Martino P. A. Kaufman L. A. Kutteh G. W. Sledge L. N. Harris J. R. Gralow
- Networks:
- Study
- NCCTG-N9831
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: